IL148595A0 - Novel cell cycle checkpoint genes and proteins encoded thereby - Google Patents

Novel cell cycle checkpoint genes and proteins encoded thereby

Info

Publication number
IL148595A0
IL148595A0 IL14859500A IL14859500A IL148595A0 IL 148595 A0 IL148595 A0 IL 148595A0 IL 14859500 A IL14859500 A IL 14859500A IL 14859500 A IL14859500 A IL 14859500A IL 148595 A0 IL148595 A0 IL 148595A0
Authority
IL
Israel
Prior art keywords
cell cycle
proteins encoded
cycle checkpoint
checkpoint genes
novel cell
Prior art date
Application number
IL14859500A
Other languages
English (en)
Original Assignee
Scripps Res Inst Janssen Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Res Inst Janssen Pharm filed Critical Scripps Res Inst Janssen Pharm
Publication of IL148595A0 publication Critical patent/IL148595A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL14859500A 1999-09-14 2000-09-14 Novel cell cycle checkpoint genes and proteins encoded thereby IL148595A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15383699P 1999-09-14 1999-09-14
PCT/US2000/025278 WO2001020038A1 (en) 1999-09-14 2000-09-14 Novel cell cycle checkpoint genes and proteins encoded thereby

Publications (1)

Publication Number Publication Date
IL148595A0 true IL148595A0 (en) 2002-09-12

Family

ID=22548950

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14859500A IL148595A0 (en) 1999-09-14 2000-09-14 Novel cell cycle checkpoint genes and proteins encoded thereby
IL148595A IL148595A (en) 1999-09-14 2002-03-10 Genes A checkpoint of the cell cycle and proteins encoded by them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL148595A IL148595A (en) 1999-09-14 2002-03-10 Genes A checkpoint of the cell cycle and proteins encoded by them

Country Status (15)

Country Link
US (3) US6440732B1 (de)
EP (1) EP1214453B1 (de)
JP (1) JP4871468B2 (de)
KR (2) KR100817010B1 (de)
AT (1) ATE404693T1 (de)
AU (1) AU784443B2 (de)
CA (1) CA2385266C (de)
DE (1) DE60039895D1 (de)
DK (1) DK1214453T3 (de)
ES (1) ES2311472T3 (de)
IL (2) IL148595A0 (de)
NO (1) NO20021255L (de)
NZ (1) NZ518236A (de)
WO (1) WO2001020038A1 (de)
ZA (1) ZA200202863B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004050674A2 (en) * 2002-12-04 2004-06-17 Algos Therapeutics, Inc. Methods and materials for modulating trpm2
US7396669B2 (en) * 2004-06-30 2008-07-08 The Scripps Research Institute Mammalian endonucleases and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801154A (en) * 1993-10-18 1998-09-01 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of multidrug resistance-associated protein
US5552390A (en) * 1993-12-09 1996-09-03 The Board Of Regents Of The University Of Nebraska Phosphorothioate inhibitors of metastatic breast cancer
WO1998041648A2 (en) * 1997-03-20 1998-09-24 Variagenics, Inc. Target genes for allele-specific drugs
US5977341A (en) * 1998-11-20 1999-11-02 Isis Pharmaceuticals Inc. Antisense modulation of inhibitor-kappa B kinase-beta expression
US7396669B2 (en) * 2004-06-30 2008-07-08 The Scripps Research Institute Mammalian endonucleases and methods of use

Also Published As

Publication number Publication date
IL148595A (en) 2008-11-26
JP4871468B2 (ja) 2012-02-08
ZA200202863B (en) 2003-09-23
CA2385266C (en) 2011-05-24
EP1214453A4 (de) 2003-02-19
US7214790B2 (en) 2007-05-08
NO20021255L (no) 2002-05-03
US7479541B2 (en) 2009-01-20
ATE404693T1 (de) 2008-08-15
CA2385266A1 (en) 2001-03-22
EP1214453A1 (de) 2002-06-19
US6440732B1 (en) 2002-08-27
WO2001020038A1 (en) 2001-03-22
JP2003509069A (ja) 2003-03-11
DK1214453T3 (da) 2008-10-13
ES2311472T3 (es) 2009-02-16
AU7581700A (en) 2001-04-17
EP1214453B1 (de) 2008-08-13
DE60039895D1 (de) 2008-09-25
US20070072794A1 (en) 2007-03-29
KR20070043872A (ko) 2007-04-25
KR20020064781A (ko) 2002-08-09
KR100817010B1 (ko) 2008-03-27
NZ518236A (en) 2004-02-27
US20070213256A1 (en) 2007-09-13
KR100851511B1 (ko) 2008-08-11
AU784443B2 (en) 2006-04-06
NO20021255D0 (no) 2002-03-13

Similar Documents

Publication Publication Date Title
PL1824977T3 (pl) Promotorowy kwas nukleinowy pochodzący z rodzaju Corynebacterium, kaseta ekspresyjna zawierająca promotor i wektor, komórka gospodarza zawierająca wektor i sposób ekspresji genu z użyciem komórki
AU2002360331A8 (en) Egviii endoglucanase and nucleic acids encoding the same
WO2000012726A3 (en) Rationally designed heparinases derived from heparinase i and ii
WO2004101760A3 (en) Novel lipolytic enzyme elip
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
ATE352626T1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
BR9813608B1 (pt) célula hospedeira de bacillus transgênica, e, processo para produzir um polipeptìdeo tendo atividade aminopeptidase.
DE69534733D1 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
WO2001029222A3 (en) Polypeptides having phospholipase b activity and nucleic acids encoding same
WO2002062999A8 (en) Proteins and nucleic acids encoding same
WO2002046409A3 (en) Proteins and nucleic acids encoding same
WO1999021976A3 (en) Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
IL155940A0 (en) Promoters exhibiting endothelial cell specificity and method of using same
ZA200202863B (en) Novel cell cycle checkpoint genes and proteins encoded thereby.
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2003066867A3 (en) Genetically engineered phic31-integrase genes
DE69828902D1 (de) Polypeptide mit 5-aminolevulinsäure synthaseaktivität und deren nukleinsäuren
WO2004029233A3 (en) Mutant recombinases
WO2000008145A3 (en) Novel genes in control of hematopoiesis
AU7645400A (en) Polypeptides having glucanotransferase activity and nucleic acids encoding same
WO2000040607A3 (en) Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
ATE547427T1 (de) Verfahren zur rekombinanten herstellung von ribonukleoproteinen
AU4395599A (en) (-)-strand rna virus vector for nerve cell
AU5233599A (en) Ddkh-3 nucleic acids, polypeptides, vectors, host cells, methods and uses thereof
ATE348109T1 (de) Das gen prv-1 und dessen verwendung

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed